Stock Ticker

  • Loading stock data...

Rite Aid Corporation (NYSE:RAD) Prepares Medicare Part D Enrollment For Next Year

Boston, MA 10/15/2014 (wallstreetpr) – Rite Aid Corporation (NYSE:RAD) disclosed that it was providing free resources to help senior customers select their plan of prescription drug for the next year. The company said that customers have the option of choosing either prescription drug plan or update their current coverage during the upcoming Medicare Part D enrollment program. The company indicated that its customers would be able to make use of their Medicare Advisor available in its pharmacy.


In a statement, Rite Aid Corporation (NYSE:RAD) said that it started providing free resources from October 15, and the customers could see three lowest-cost plans of prescription drug based on the existing prescriptions filed at its stores. The enrollment period runs till December 7 in the current year.

Rite Aid said that it was committed to providing informative, convenient and ready-to-understand resources to support its customers make the right decisions to accomplish their individual health, as well as, wellness goals. Rite Aid Corporation (NYSE:RAD) stated that prescriptions have a key role in keeping good heath. Therefore, it urged its customers to review their prescription drug coverage every year.

Rite Aid Corporation (NYSE:RAD) pointed out that its Medicare Advisor was a worthwhile tool for its customers to evaluate their prescription plan. Its pharmacies can be accessible through the nation to help customers confidently select the best plan depending upon prescription requirements.

Comparison Of Costs

Rite Aid said that its Medicare Advisor enabled customers compare the projected annual costs of different plans, including monthly premium, generic and brand co-pays and coverage of drugs. It said that customers could easily discuss their Medicare Advisor report with its pharmacists, who would be in a position to come out with answers for the questions they might have.

Rite Aid Corporation (NYSE:RAD) was offering exclusive provider of co-branded preferred pharmacy for its Symphonix Rite Aid Premier Rx PDP. It indicated that there was no deductible for those enrolled in the plan.

Published by Christine Lawrence

Christine Lawrence is a financial analyst. She loves analyzing socioeconomic trends in the background of financial moves. She has overall seven years of experience in Auditing, Finance and Writing.

  • Recent Stories

    SignUp Now For Our Featured Newsletter

    Sign Up To Get Our Latest Stocks Alerts